300653 正海生物
按盤價 
21.790 +1.610 (+7.978%)
21.790 +1.610 (+7.978%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.171 | 21.063 | 22.472 | 23.541 | 19.162 |
| 總資產報酬率 ROA (%) | 3.785 | 18.715 | 19.358 | 19.436 | 15.509 |
| 投入資產回報率 ROIC (%) | 4.041 | 20.226 | 21.433 | 22.036 | 18.009 | 邊際利潤分析 |
| 銷售毛利率 (%) | 87.302 | 89.901 | 88.723 | 89.106 | 92.228 |
| 營業利潤率 (%) | 53.548 | 52.839 | 48.952 | 47.936 | 45.592 |
| 息稅前利潤/營業總收入 (%) | 53.262 | 52.655 | 48.753 | 47.451 | 45.090 |
| 淨利潤/營業總收入 (%) | 45.051 | 46.164 | 42.804 | 42.120 | 40.348 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 86.978 | 87.543 | 93.008 | 87.145 | 88.034 |
| 價值變動淨收益/利潤總額(%) | 10.929 | 11.569 | 3.393 | 8.321 | 5.049 |
| 營業外收支淨額/利潤總額(%) | 0.000 | -0.080 | 0.017 | -0.129 | 2.031 | 償債能力分析 |
| 流動比率 (X) | 10.527 | 8.562 | 6.723 | 5.264 | 3.636 |
| 速動比率 (X) | 10.071 | 8.154 | 6.337 | 4.994 | 3.473 |
| 資產負債率 (%) | 8.477 | 10.036 | 12.341 | 15.464 | 0.197 |
| 帶息債務/全部投入資本 (%) | 0.918 | 2.205 | 2.366 | 3.002 | 5.906 |
| 股東權益/帶息債務 (%) | 10,632.727 | 4,362.996 | 4,050.358 | 3,160.192 | 1,559.819 |
| 股東權益/負債合計 (%) | 1,079.618 | 896.437 | 710.287 | 546.656 | 407.200 |
| 利息保障倍數 (X) | -185.926 | -369.890 | -235.612 | -112.176 | -31.163 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 52.806 | 42.093 | 37.683 | 44.186 | 63.713 |
| 存貨周轉天數 (天) | 282.359 | 333.560 | 275.121 | 237.913 | 329.755 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 03/07/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
